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1. Introduction
The Protein Data Bank in Europe (PDBe; http://pdbe.org;
Velankar et al., 2010, 2011), previously known as the European
Macromolecular Structure Database (MSD; Velankar et al.,
2005; Tagari et al., 2006), is the European partner in
the Worldwide Protein Data Bank (wwPDB; http://
wwpdb.org; Berman et al., 2007). Together with its wwPDB
partners, RCSB (Kouranov et al., 2006), PDBj (Standley et al.,
2008) and BMRB (Ulrich et al., 2008), PDBe accepts deposi-
tions of experimentally determined biomacromolecular
structures and the underlying experimental data. The
deposition sites curate (i.e. annotate, enrich and validate) the
structures and the data and make them available in the
Protein Data Bank (PDB; Bernstein et al., 1977; Berman,
2008). The PDB is the single worldwide archive of bioma-
cromolecular structures. The master copy of the PDB resides
on an ftp server hosted by RCSB, with mirrors at PDBe and
PDBj. The weekly updates of the PDB are released by all of
the wwPDB sites simultaneously at 0:00 UTC (Coordinated
Universal Time) on Wednesdays. The archive is freely down-
loadable and is mirrored by many third-party sites. The
wwPDB partners collaborate intensely on all matters related
to ‘data-in’; that is, the deposition and annotation of structures
and data and issues related to formats, standards, validation
and the description of the ligands that occur in the PDB.
However, as regards ‘data-out’ they each offer different and
competing services, thus providing alternative ways of deli-
vering and presenting the data in the PDB to the user
community through their individual websites.
PDBe was established (initially as MSD) at the European
Bioinformatics Institute (EMBL–EBI; http://www.ebi.ac.uk)
in 1995. Under the leadership of Geoff Barton (1998–2001)
andKimHenrick (2001–2009), PDBe builtup areputationasa
provider of advanced structural bioinformatics databases and
services. PDBe also founded the Electron Microscopy Data
Bank (EMDB; http://emdatabank.org; Tagari et al., 2002;
Henrick et al., 2003) in 2002. However, like the PDB, EMDB
is now an international collaborative effort involving PDBe,RCSB and the laboratory of Wah Chiu at Baylor College of
Medicine (BCM) (Lawson et al., 2011).
In this paper, we discuss some of the challenges facing the
PDB and its guardians in the near future. Subsequently, we
describe the areas inwhichPDBe has traditionally been strong
or wants to become strong as well as some of our future plans
in these areas. Finally, we discuss some recent developments at
PDBe.
2. The future of the PDB
There is no doubt that the future of the PDB will involve
growth: growth in the number of entries, growth in the size and
complexity of entries and growth in the number of experi-
mental techniques (including so-called hybrid methods) that
are used to determine the structures of biologically relevant
molecules, complexes and machines at anything from very low
to atomic resolution. These developments will have profound
consequences for PDBe, for wwPDB and for all producers and
users of biomacromolecular structures. The wwPDB partners
are currently developing a new common deposition and
annotation tool that will enable them to handle a greater
number of more complex and more diverse structures (and the
underlying experimental data) produced by a number of
different experimental methods. As structures have become
larger and more complex, the limits of the original PDB
format (Bernstein et al., 1977) have been reached (and in some
cases breached). For this reason, the wwPDB partners, in
consultation with community stakeholders, are developing a
new more versatile PDB format. Another important area in
which the wwPDB partners have joined forces is the validation
of structures and data (Kleywegt, 2009). wwPDB has estab-
lished validation task forces (VTFs) for X-ray crystallography
(Berman et al., 2010), NMR spectroscopy and cryoelectron
microscopy (EM). The recommendations of these task forces
will be implemented as part of the deposition and annotation
pipeline. The new system will include validation of small
molecules bound to macromolecules. These small molecules
form an increasingly important component of the structure
data available in the archive, but validation of their structures
and reliability has been problematic (Kleywegt, 2007). To
remedy this problem, wwPDB has entered into a collaboration
with the Cambridge Crystallographic Data Centre (CCDC;
http://www.ccdc.cam.ac.uk/), giving the wwPDB partners
access to CCDC tools and databases. In particular, Mogul
(Bruno et al., 2004), a program for validation of the geometry
of small molecules, will become a crucial component of the
wwPDB ligand-validation arsenal.
As the PDB approaches its 40th birthday in 2011, every-
body involved with it faces an important question: should the
PDB should remain a historic archive or not? The PDB has
hitherto been an archive of the structural data as described in
the primary literature. For instance, the coordinates available
in the PDB for a structure determined in 1976 are those
described in that year, even though model-building, reﬁne-
ment and validation methodology has advanced enormously
since then. Even automatic approaches could produce
improved models for the vast majority of crystal structures in
the PDB today (Joosten et al., 2009). The PDB is very much a
provider-centric archive, which is great for crystallographers
and historians but which severely limits the accessibility and
usefulness of structural data to non-expert users. Shifts in user
communities and user demands, as well as limits on the
resources and funding sources available for the maintenance
and development of the PDB, put pressure on the structural
biology community as a whole to make its ﬁndings more
accessible, and indeed relevant, to large groups of non-expert
users (from medicinal chemists to geneticists and physicians).
In our view, during its ﬁfth decade the PDB should be trans-
formed from a historical archive into a useful resource for
biomedicine (and related ﬁelds such as agriculture). Non-
expert users approach the structural archive very differently
from structural biologists. They generally think in terms of
genes, proteins, pathways, mutations or diseases, not in terms
of PDB ID codes. Furthermore, non-experts have great difﬁ-
culty in telling a good and reliable structure model of a certain
molecule from a poor one. These observations have a number
of implications for the way in which the structural archive
needs to be organized and presented to such users.
(i) There is a need for new ways of searching for structural
information. Whereas a structural biologist can usually locate
a structure of a molecule or complex of interest using text-
based or sequence searches, non-experts who think in terms
of, for instance, pathways or diseases should be able to browse
the structural knowledge base using concepts, terms and
classiﬁcations that are relevant and familiar to them.
(ii) There is a need for new ways of handling structural
information. Rather than a search or browse operation
resulting in a list of hits (PDB entries that match a set of
criteria), the non-expert user may want to take these hits and
carry out certain tasks, ranging from visualization, super-
position and structure-based sequence alignment to mapping
of SNP data or comparison of binding sites. As the example of
SNP mapping shows, structural data presented in isolation are
of only limited use. Integration of multiple sources of bio-
logical data and information will add signiﬁcant value and will
help non-expert users to answer complex questions that
involve three-dimensional structure.
(iii) There is a need for best-practice structural models. A
non-expert user will rarely be interested in the exact coordi-
nates as they were deposited when a structure was published.
Instead, they will assume that the model they download is the
best possible interpretation of the experimental data obtained
using state-of-the-art methods. Obviously, the historic data
need to be available as well, but it is untenable in the long run
to put the onus on the user when it comes to obtaining a best-
practice model. Related to this is the need to provide infor-
mation about the quality of models so that the most suitable
model can be selected from amongst a number of alternatives,
even by non-experts. This need will be addressed by the
wwPDB VTFs.
Some of these requirements have implications for wwPDB
as a whole, while others apply to all sites that deliver raw and
derived PDB data, including PDBe.
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PDBe has identiﬁed ﬁve focus areas in which it either has
traditionally been strong or wants to become strong in the
near future, namely (i) advanced services, (ii) ligand annota-
tion and analysis, (iii) integration and presentation of bio-
molecular and other data, (iv) validation and (v) experimental
data (presentation, validation and analysis). Some past activ-
ities and some ongoing and future developments in each of
these areas are described below.
3.1. Advanced services
PDBe has established a reputation as a provider of
advanced databases and services built upon the data available
in the PDB and other resources, including the following.
(i) PDBeFold (Krissinel & Henrick, 2004a,b). This service
can be used to compare a protein structure with all the protein
structures in the PDB or against the domains covered by
the SCOP structure-classiﬁcation database (Andreeva et al.,
2008). The method is based on a subgraph-isomorphism-
detection algorithm developed at PDBe and implemented in
the program SSM (Krissinel & Henrick, 2004a,b). This algo-
rithm is fast and allows structure comparison against the entire
PDB in a matter of minutes. For every similar structure found,
the output includes details of the matching secondary-
structure elements and residues, and superimposed structures
can be visualized.
(ii) PDBePISA (Krissinel & Henrick, 2007). This can be
used for prediction and analysis of the probable quaternary
structure of a crystal structure. It is also used in the annotation
of structures in the PDB and replaces the older PQS service
(Henrick & Thornton, 1998). All of the predicted quaternary
structures can be downloaded and the server provides a
detailed analysis of all interfaces. It is also possible to search
similar interfaces in the entire PDB based only on the three-
dimensional arrangement of the residues in an interface.
(iii) PDBeMotif (Golovin et al., 2005; Golovin & Henrick,
2008, 2009). This service can be used for exploration of ligand-
binding sites and small three-dimensional structural motifs
across the entire PDB archive. PDBeMotif also integrates
sequence-based annotation information using DAS tech-
nology (Dowell et al., 2001) and allows users to compare this
information with annotations based on the three-dimensional
structure. It is possible to examine the ligand-binding char-
acteristics of a single protein or of groups of proteins based on
classiﬁcations such as EC (Fleischmann et al., 2004), Pfam
(Finn et al., 2010), CATH (Greene et al., 2007) and SCOP.
3.2. Ligands
The ligand-bound structures in the PDB offer unique
insights into the molecular interactions of small molecules and
biomacromolecules. In many instances ligands modulate the
activity of the protein to which they bind, but sometimes their
presence is an artefact of the experimental procedure (e.g.
puriﬁcation or crystallization). Nevertheless, even ‘accidental’
ligands can offer insight into how the natural substrate might
interact with its biomacromolecular target. The process of
identifying ‘interesting’ ligands will usually require manual
annotation. PDBe has started a pilot project on the annotation
of such ligand instances based on the simple rule that if a
ligand and its environment are discussed in the primary
publication of the PDB entry then it is likely to be ‘inter-
esting’. The ligand is then classiﬁed as ‘biologically interesting’
or ‘experimentally interesting’ (e.g. a small molecule bound at
a crystallographic special position) and this classiﬁcation and
supporting information are stored in a database for future use.
Presenting protein–ligand interaction data to the wider
community presents another challenge, since understanding
the three-dimensional nature of the interaction site is not
straightforward. Approaches such as LigPlot (Wallace et al.,
1996) have been successful in making this information acces-
sible as simpliﬁed two-dimensional diagrams with key details
about the molecular interactions. The two-dimensional
approach, while sophisticated, still has the limitation of not
conveying the three-dimensional nature of the binding site. At
PDBe we are working to combine customisable and linked
two-dimensional and three-dimensional views. Together with
annotation of ‘interesting ligands’ this will enhance the value
of the PDB archive.
3.3. Integration
PDBe is part of the European Bioinformatics Institute
(EBI), which is home to a number of core bioinformatics
databases and services that hold data relevant to the bio-
medical ﬁeld (Brooksbank et al., 2010). This puts PDBe in a
unique position and enables it to enhance the annotation of
biological data with insights from the macromolecular struc-
ture information available in the PDB and vice versa.T h i s
approach to data integration has been a mainstay of the
bioinformatics ﬁeld in the past decade (Chicure, 2002;
Valencia, 2002). PDBe collaborates primarily with UniProt
(UniProt Consortium, 2009) to integrate information from
protein sequences and structures. This collaboration, which
started in 2000, has resulted in a data resource called SIFTS
(Structure Integration with Function, Taxonomy and
Sequences; Velankar et al., 2005). SIFTS is the authoritative
source of up-to-date residue-level annotation of structures in
the PDB with data available in UniProt, CATH (Greene et al.,
2007), SCOP (Andreeva et al., 2008), GOA (Barrell et al.,
2009), InterPro (Hunter et al., 2009) and Pfam. SIFTS itself
is used by major resources such as Pfam, CATH, RCSB,
DAS server providers (http://www.dasregistry.org/) and many
research and service groups around the world. In the future,
SIFTS might be extended to link PDB data to other resources
such as ChEMBL (http://www.ebi.ac.uk/chembl/; protein–
ligand interaction data), IntAct (Aranda et al., 2010; macro-
molecular interaction data), Reactome (Matthews et al., 2009;
biological pathway data), ChEBI (De Matos et al., 2010; ligand
chemistry and function data) and EnsEMBL (Flicek et al.,
2010; SNPs and genetic variation data).
Although data-integration efforts have resulted in an
infrastructure that allows the easy transfer of information and
research papers
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bioinformatics resources, this in
itself does not necessarily result
in additional insight into the
biological context, function or
role of a given biomacromolecule.
Intelligent query and visualiza-
tion mechanisms using modern
tools and technologies are essen-
tial for making structure data
relevant for the wider biomedical
ﬁeld. Efforts to develop such
tools are under way at PDBe and
some initial results are described
in x4.
3.4. Validation
It is generally difﬁcult for non-
expert users of structural data to
assess the reliability of the data
and inferences based on a
macromolecular structure (Kley-
wegt, 2009). To address this issue,
PDBe will create a validation
portal for biomacromolecular
structure data. As a ﬁrst step, the
Uppsala Electron Density Server
(EDS; Kleywegt et al., 2004) will
be integrated into the PDBe
infrastructure. The results of the
wwPDB validation pipeline will
be combined with electron-
density data and presented in an
integrated validation viewer for
X-ray crystal structures. Similar
functionality will be developed
for structures determined by
other experimental methods as
the VTFs submit their recom-
mendations to the wwPDB part-
ners.
3.5. Experimental data
NMR contributes about 15%
of the structures in the PDB
archive. This technique presents
several distinct challenges com-
pared with X-ray crystallography,
especially with regard to data complexity, consistent data
storage and diversity of software. To encourage the commu-
nity to tackle these issues before deposition, PDBe has been
collaborating closely with the Collaborative Computational
Project for NMR (CCPN) for the last decade (Fogh et al., 2006;
Vranken et al., 2005). This work has resulted in a deposition
system where NMR spectroscopists can upload a complete
CCPN project to PDBe from which all information relevant to
the PDB is extracted (Penkett et al., 2010) and NMR data are
forwarded to the BioMagResBank (BMRB; Ulrich et al.,
2008). These efforts on consistent data storage have also
resulted in software to handle a large variety of NMR data
formats (Vranken et al., 2005) and are used in data-cleanup
projects (Doreleijers et al., 2005, 2009) and the CASD–NMR
software-assessment competition (Rosato et al., 2009). The
large data archives created in this way have made it possible to
research papers
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Figure 1
The new PDBe home page, where the top search bar provides a common interface for simple searches of
both PDB and EMDB. The ‘Quick access’ panel allows users to perform the most common tasks such as
ﬁnding detailed information about a particular PDB entry, searching the PDB by various database
identiﬁers or searching the PDB based on a protein sequence. The menu on the left provides access to many
of the PDBe search and browse tools.
Figure 2
Example of an Atlas page, in this case for PDB entry 1lyz. The menu on the left-hand side enables
navigation between different areas of information and provides links to other resources and downloadable
ﬁles. The main panel on the right shows the summary information for the entry.carry out comprehensive data analyses (Vranken, 2007;
Vranken & Rieping, 2009) and structure recalculations
(Nederveen et al., 2005; Nabuurs et al., 2004) and have driven
new developments in the ﬁeld (De Simone et al., 2009; Rieping
& Vranken, 2010). PDBe continues to work with the NMR
community to ensure that there is a public archive with
structures that are supported by well deﬁned experimental
data. PDBe is also committed to delivering these data back to
the community in forms that encourage further developments
in the ﬁeld of biomacromolecular NMR spectroscopy.
Since 2002, PDBe has worked closely with the EM
community in establishing and developing the Electron
Microscopy Data Bank (EMDB; Tagari et al., 2002). Initially
a purely European affair, the archive is now operated and
developed jointly by the three EMDB partner sites PDBe,
RCSB and BCM. A deposition and annotation system for EM
data was developed at PDBe (Henrick et al., 2003) and is now
available at PDBe and RCSB. The EMDB partner sites are
also working on integrating the three-dimensional structure
data available in the PDB with EM volume data. The EMDB
data can be accessed through the joint website at http://
EMDataBank.org (Lawson et al., 2011).
In addition to the presentation and analysis of NMR and
EM data, the integration of EDS into the PDBe service
infrastructure will deliver up-to-date electron-density maps
and analyses based on the ﬁt of models and data to the user
community.
4. New developments at PDBe
PDBe has begun the process of addressing the needs of new
communities of users who are not experts in structural biology,
a process that is likely to take 5–10 years. In the summer of
2010, PDBe launched its redesigned website (http://pdbe.org;
Velankar et al., 2011; Fig. 1) which included a number of new
features that may be considered ﬁrst steps on the road to its
becoming a useful resource for biomedicine. The home page
of PDBe was completely redesigned, with the express aim of
making it easier and more intuitive to locate information,
resources and services, even for ﬁrst-time non-expert users.
This is achieved by offering menus that describe services and
resources by their function rather than by an arcane name, by
providing a single search box in the top bar on the home page
which will search both PDB and EMDB simultaneously and
by providing a number of quick-access tools to retrieve key
data based on PDB ID code. The PDBe database can also
be queried using database identiﬁers for various relevant
resources such as PubMed, Pfam, SCOP, CATH, EC and
InterPro. It is further possible to carry out FASTA (Lipman &
Pearson, 1985) searches against all protein sequences in the
PDB from the home page.
A tool to help new users of the website ﬁnd the information
that they are looking for is the PDBe Wizard (http://pdbe.org/
wizard). The Wizard ﬁrst tries to establish what the user is
looking for and what information they already have. Based on
this, it either provides the user with a box in which to enter
some input (e.g. a PDB code, author name or UniProt ID) and
start a search or it provides a link to a resource or service or
a page with more information. At the stage where input is
required, there are two helpful buttons. One, labelled
‘Shortcut’, provides hints on how to carry out the same search
more quickly using PDBe services directly. The other, labelled
‘What results will I get?’, shows examples of what results can
be expected and how they will be presented.
For every PDB entry there is set of ‘atlas’ pages that
provide important information about the structure determi-
nation, the sequences of the biomacromolecules, the
secondary structure of any proteins, the probable quaternary
structure, literature references etc. The URLs for these pages
are of the form http://pdbe.org/1cbs, where ‘1cbs’ is an
example of a PDB ID code of interest. By default, a summary
page will be presented that uses plain-English sentences to
describe key aspects of the structure and the study, as well as
some ﬁgures and tables with cross-references to other data-
bases (Fig. 2).
PDBe has introduced a new method to convey information
about key aspects of a PDB entry using intuitive icons called
PDBlogos (http://pdbe.org/pdbprints; Fig. 3). In order to make
research papers
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Figure 3
PDBlogos and PDBprints. (a) PDBlogos are stylized icons that convey
important information about a PDB entry. For example, these two
PDBlogos signify that the biomacromolecule in an entry derives from a
fungus and that the structure was determined by X-ray crystallography,
respectively. (b) By default, PDBlogos are shown on a green background
(although this may be set to a different colour on external websites).
However, sometimes the background will be grey: this signiﬁes that either
the feature symbolized by the PDBlogo is absent or that the underlying
data are not available, not published or not deposited. For instance, these
two PDBlogos show that an entry does not contain any nucleic acid
molecules and that the structure has not (yet) been published,
respectively. (c) A PDBprint for a PDB entry is a collection of PDBlogos
displayed in a speciﬁc order, where each icon represents a well deﬁned
category of information (see text). This PDBprint shows immediately that
PDB entry 1cbs is a published crystal structure of a heterologously
expressed human protein in complex with a ligand for which the
experimental diffraction data have beeen deposited. To help users
familiarize themselves with the meaning of PDBlogos, tool tips are
presented.the interpretation of the information conveyed by PDBlogos
easier and to provide consistent information when a number
of PDB entries are compared, PDBe has also developed
PDBprints. A PDBprint for a PDB entry is a collection of
PDBlogos displayed in a speciﬁc order, where each icon
represents a well deﬁned category of information. In the ﬁrst
release of PDBprints (summer 2010) the following categories
are included:
(i) Primary citation: has the PDB entry been published?
(ii) Taxonomy: what is the source organism of the bio-
macromolecule(s) in the entry?
(iii) Sample-production tech-
nique: how was the sample
of the biomacromolecule(s)
obtained?
(iv) Structure-determination
method: which experimental
technique(s) was used to deter-
mine the structure and were the
experimental data deposited?
(v) Protein content: does the
entry contain any protein mole-
cules?
(vi) Nucleic acid content: does
the entry contain any nucleic acid
molecules (DNA, RNA or a
hybrid)?
(vii) Heterogen content: does
the entry contain any ligands
(such as inhibitors, cofactors, ions,
metals etc.)?
Fig. 3(c) shows the PDBprint
for PDB entry 1cbs, which shows
that 1cbs is a published crystal
structure of a heterologously
expressed human protein in
complex with a ligand for which
the experimental diffraction data
have been deposited.
In a ﬁrst attempt to enable
users to access the structure
archive using familiar biological
classiﬁcations and to analyse the
selected structures in a number
of ways, PDBe has introduced
a database browser called
PDBeXplore. At present, there
are three browser modules based
on the following classiﬁcation
systems:
(i) the enzyme-classiﬁcation
(EC) system as included in the
IntEnz (De Matos et al., 2010)
database (http://pdbe.org/ec),
(ii) the sequence-based protein-
family classiﬁcation system
(http://pdbe.org/pfam) and
(ii) the fold-based protein-family classiﬁcation system
CATH (http://pdbe.org/cath).
Fig. 4 shows a glimpse of the enzyme-browser functionality.
The browser not only lists all the PDB entries that are relevant
for a given query but also provides instant reports and
analyses of the relevant structure data. These reports pertain
to
the distribution of probable quaternary structures, bound
ligands, sequence-family data (based on Pfam), taxonomy and
fold classiﬁcations. All of the information can be downloaded
research papers
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Figure 4
The PDBe enzyme-browser tool. The left-hand panel shows the EC classiﬁcation as a tree and the right-
hand panel gives detailed information on the selected class of enzyme. The central panel shows structure
data relevant to theselected EC class organized asa number oftabs (e.g. ligands,quaternary structure,folds
etc.).
Figure 5
The PDBe browser for analysing the results of sequence searches against the PDB. The query sequence can
be shown aligned with each of the target sequences, together with their secondary structure, Pfam and
CATH domain annotations.for further off-line use. PDBe offers similar browser func-
tionality for sequence-based searches (http://pdbe.org/fasta).
This tool offers a list of all PDB entries that include proteins
that have a sequence similar to the query sequence and
provides additional analyses and reports. The browser also
shows the alignment of the query and target sequences with
annotation about secondary-structure assignment and CATH
and Pfam domains (Fig. 5).
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